Suhail Shaikh
Analyst · Raymond James. Robert, go ahead please
Thank you, Mike. As Mike mentioned, this quarter's activity was characterized by secondary opportunities. Market estimates had direct lending volume in this quarter down almost 50% year-over-year. However, we're beginning to see primary deal flow pick up after the summer slowdown. We're being highly selective in this credit environment, whether we are evaluating a primary or a secondary transaction. Our primary focus remains investing in high cash flow generating businesses with enhanced structural protections and supported by experienced sponsors. During the quarter, we invested in two new portfolio companies and two existing portfolio companies, as Mike mentioned. We also fully realized our position in one of the portfolio companies. During the quarter, fundings for commitments and new investments totaled approximately $15.1 million of cost, with a weighted average yield of approximately 15.5%. In the same period, repayments totaled approximately $8.7 million from one investment with an IRR of approximately 9.8%. To talk you through the new investments. First, we made an investment in the first-lien term loan of AMCP Clean Acquisition Company, also known as PureStar. This is a good example of an opportunistic secondary purchase of a credit that we have been tracking. PureStar is a portfolio company of Cornell Capital. It is one of the largest commercial monitory providers in the hospitality industry in the U.S. We invested in the first-lien term loan and delayed to our term loan. Our yield at cost is approximately 16.5%. Second, we invested in the first-lien term loan of America’s Auto Auction, also known as XLerate. This is an example of an investment that we own in another portfolio and we're able to find an attractive opportunity to purchase in the secondary market. Our BrightStar Capital portfolio company XLerate is a full service, used vehicle auction services provider for [indiscernible] customer. Our yield at cost is approximately 13.6%. Finally, we invested in the priority term loan of Bioplan. Bioplan provides packaging and sampling solutions to the beauty and fragrance industry. Our yield at cost is approximately 13.6%. During this quarter, we fully realized our position in auto and marketing, which was refinanced. Our fully realized IRR was approximately 9.8%, as I mentioned above. After quarter-end, we invested in one new portfolio company and one existing portfolio company. First, we invested in the first-lien term loan of Axiom Global. Axiom is a leading and global provider of expertise of talent offering legal counseling and representation services. Axiom was a portfolio company of Permira. We have been an investor in Axiom for a few years in our other portfolios and similar to XLerate, we've been able to purchase it at an attractive price. Our yield at cost is approximately 10.1%. We also made a follow-on secondary investment in PureStar. Our yield at cost is approximately payments original investment of 16.5%. I'd like to note that the GICS standard was updated in May of this year. As such, our industry categorization for existing portfolio companies has changed in some cases, and our industry ratings have also changed. As of June 30, our largest industry concentrations were the following; trade company and distributors at 16%; professional services at 12.8% followed by IT services at 10.7%. Commercial services and supplies at 6.5% and software at 6.2%. Our portfolio companies are in 21 GICS industries, as Mike mentioned, as of quarter-end, including high equity and warrant positions. I'd now like to turn the call back over to Rocco to discuss our financial results.